ZF Pharma Summit 2017

Christian Rodseth, Janssen: Romania’s Medicine Pricing Methodology Makes No Sense

09.13.2017 By Ecaterina Craciun

The medicine pricing methodology and the clawback tax paid by drug producers are the main obstacle on the Romanian pharmaceutical market and the risk patients are subject to comes from a lack of drugs on the market, said Christian Rodseth, managing director Janssen, pharmaceutical companies of Johnson & Johnson.



To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
Janssen Pharmaceutical
, medicine price

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.